In the Phase III LIBERTY-UC and LIBERTY-CD studies, Zymfentra elicited higher rates of clinical remission than placebo in patients with moderate-to-severe UC and CD, respectively, following induction with intravenous infliximab
- Selenium: 20 mcg (36.4% VNR)
To the end Omizzur Bio-custom peptide synthesis business include : pharmaceutical peptides, clinical peptides, stapled peptides, starch peptides, aldehydes, cyclic peptides, disulfide bond bridging peptides, transmembrane peptides, various antimicrobial peptides, cosmetic peptides, phosphorylated peptides, PEG peptides, BSA and KLH coupling antigen peptides, various acid modified peptides, various amine compound modified peptides (aniline, isoamylamine, diethylamine), various glory labels ( FITC, FAM series, DOTA, TAMRA series, Cy series) isotope peptides, etc
& Underwood, L